Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 7 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Gastric Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Immune Checkpoint Inhibition 1 ESCC 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Bites and Stings 1 Advanced Hepatocellular Carcinoma 1

Interventions

Radiosurgery 7 lenvatinib 5 Radiofrequency Ablation 5 Electroporation 5 Radiotherapy 3 Patient Navigation 3 Laparoscopy 3 Hepatectomy 3 Exercise 3 sintilimab 2 perflutren 2 Surgical Procedures, Operative 2 Standard of Care 2 Proton Therapy 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Bupivacaine 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × camrelizumab × Clear all

NCT05339581 2022-04-27

iPLENTY-pvtt

RenJi Hospital

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡